Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
Explore more from The Transmitter
Autism in Kenya, organoid research, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 December.
Autism in Kenya, organoid research, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 22 December.
‘Unprecedented’ dorsal root ganglion atlas captures 22 types of human sensory neurons
The atlas also offers up molecular and cellular targets for new pain therapies.
‘Unprecedented’ dorsal root ganglion atlas captures 22 types of human sensory neurons
The atlas also offers up molecular and cellular targets for new pain therapies.
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.
Not playing around: Why neuroscience needs toy models
Amid the rise of billion-parameter models, I argue that toy models, with just a few neurons, remain essential—and may be all neuroscience needs.